XML 34 R22.htm IDEA: XBRL DOCUMENT v3.25.0.1
SEGMENT INFORMATION
 3 Months Ended
Jan. 03, 2025
Segment Reporting [Abstract]  
SEGMENT INFORMATION SEGMENT INFORMATION
    The Company has two reportable operating segments: Medical and Industrial, which aligns with how the CODM reviews the Company’s performance. The segments align the Company’s products and service offerings with customer use in medical and industrial and are consistent with how the Company’s CEO evaluates the business for the allocation of resources. The CODM allocates resources to and evaluates the financial performance of each operating segment primarily based on revenues and gross profit. The operating and reportable segment structure provides alignment between business strategies and operating results.
Description of Segments
    The Medical segment designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. These components are used in a range of medical imaging applications including CT, mammography, oncology, cardiac, surgery, dental, and other diagnostic radiography uses.
    The Industrial segment designs, develops, manufactures, sells and services X-ray imaging products for use in a number of markets, including security applications for cargo screening at ports and borders, baggage screening at airports, and nondestructive testing, irradiation, and inspection applications used in a number of other vertical markets. The Company's industrial products include Linatron® X-ray linear accelerators, X-ray tubes, digital detectors, high voltage connectors, and coolers. In addition, the Company licenses proprietary image-processing and detection software designed to work with other Varex products to provide packaged sub-assembly solutions to industrial customers.
    Accordingly, the following information is provided for purposes of achieving an understanding of operations, but it may not be indicative of the financial results of the reported segments were they independent organizations. In addition, comparisons of the Company’s operations to similar operations of other companies may not be meaningful.
    Information related to the Company’s segments is as follows:
Three Months Ended
(In millions)January 3, 2025December 29, 2023
Revenues, net
Medical$144.6 $139.9 
Industrial55.2 50.1 
Total revenues199.8 190.0 
Gross profit
Medical49.5 38.9 
Industrial19.0 18.2 
Total gross profit68.5 57.1 
Total operating expenses57.3 52.9 
Interest and other expense, net(8.7)(4.8)
Income (loss) before taxes2.5 (0.6)
Income tax expense (benefit)2.6 (0.2)
Net loss(0.1)(0.4)
Less: Net income attributable to noncontrolling interests0.2 0.1 
Net loss attributable to Varex$(0.3)$(0.5)
    The Company does not disclose total assets by segment as this information is not provided to the CODM.